APA (7th ed.) Citation

LR, W., PJ, P., DJ, G., K, B., RL, W., S, D., . . . RL, B. (2013). Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33. Pathology, 45(7), 629. https://doi.org/10.1097/PAT.0000000000000004

Chicago Style (17th ed.) Citation

LR, Webster, et al. "Prohibitin Expression Is Associated with High Grade Breast Cancer but Is Not a Driver of Amplification at 17q21.33." Pathology 45, no. 7 (2013): 629. https://doi.org/10.1097/PAT.0000000000000004.

MLA (9th ed.) Citation

LR, Webster, et al. "Prohibitin Expression Is Associated with High Grade Breast Cancer but Is Not a Driver of Amplification at 17q21.33." Pathology, vol. 45, no. 7, 2013, p. 629, https://doi.org/10.1097/PAT.0000000000000004.